Robust Bayesian approaches for clinical trial monitoring

Statistics in Medicine

Volumn 15, Issue 11, 1996, Pages 1093-1106

  Carlin, Bradley P ^a   Sargent, Daniel J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PYRIMETHAMINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BAYES THEOREM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; ENCEPHALITIS; HUMAN; MONITORING;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; BAYES THEOREM; CONTROLLED CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; ENCEPHALITIS; HUMANS; PLACEBOS; PYRIMETHAMINE; TOXOPLASMOSIS;

EID: 0029898589     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19960615)15:11<1093::AID-SIM231>3.0.CO;2-0     Document Type: Article

References (22)

1. Brophy, J. M. and Joseph, L. 'Placing trials in context using Bayesian analysis', Journal of the American Medical Association, 273, 871-875 (1995).
2. Lan, K. K. G. and DeMets, D. L. 'Discrete sequential boundaries for clinical trials', Biometrika, 70, 659-663 (1983).
3. Berry, D. A. 'A case for Bayesianism in clinical trials' (with discussion), Statistics in Medicine, 12, 1377-1404 (1993).
4. Spiegelhalter, D. J., Freedman, L. S. and Parmar, M. K. B. 'Applying Bayesian ideas in drug development and clinical trials', Statistics in Medicine, 12, 1501-1511 (1993).
5. Spiegelhalter, D. J., Freedman, L. S. and Parmar, M. K. B. 'Bayesian approaches to randomised trials' (with discussion), Journal of the Royal Statistical Society, Series A, 157, 357-416 (1994).
6. Carlin, B. P. and Louis, T. A. 'Identifying prior distributions that produce specific decisions, with application to monitoring clinical trials', in Berry, D., Chaloner, K. and Geweke, J. (eds), Bayesian Analysis in Statistics and Econometrics: Essays in Honor of Arnold Zellner, Wiley, New York, in press.
7. Sargent, D. J. and Carlin, B. P. 'Robust Bayesian design and analysis of clinical trials via prior partitioning', Research Report 94-016, Division of Biostatistics, University of Minnesota, 1994.
8. Edwards, W., Lindman, H. and Savage, L. J. 'Bayesian statistical inference for psychological research', Psychological Review, 70, 193-242 (1963).
9. Berger, J. O. 'An overview of robust Bayesian analysis' (with discussion), Test, 3, 5-124 (1994).
10. Berger, J. O. and Sellke, T. 'Testing a point null hypothesis: The irreconcilability of p values and evidence' (with discussion), Journal of the American Statistical Association, 82, 112-122 (1987).
11. Berger, J. O. and Delampady, M. 'Testing precise hypotheses' (with discussion), Statistical Science, 2, 317-352 (1987).
12. O'Hagan, A. and Berger, J. O. 'Ranges of posterior probabilities for quasiunimodal priors with specified quantiles', Journal of the American Statistical Association, 83, 503-508 (1988).
13. Greenhouse, J. B. and Wasserman, L. A. 'Robust Bayesian methods for monitoring clinical trials', Statistics in Medicine, 14, 1379-1391 (1995).
14. Berger, J. O. and Berliner, L. M. 'Robust Bayes and empirical Bayes analysis with ε-contaminated priors', Annals of Statistics, 14, 461-486 (1986).
15. Berger, J. O. and O'Hagan, A. 'Ranges of posterior probabilities for unimodal priors with specified quantiles' (with discussion), in Bernardo, J. M., DeGroot, M. H., Lindley, D. V. and Smith, A. F. M. (eds), Bayesian Statistics 3, Oxford University Press, Oxford, 1988, pp. 45-65.
16. Lavine, M., Wasserman, L. and Wolpert, R. L. 'Linearization of Bayesian robustness problems', Journal of Statistical Planning and Inference, 37, 307-316 (1993).
17. Kass, R. E. and Raftery, A. E. 'Bayes factors', Journal of the American Statistical Association, 90, 773-795 (1995).
18. Jacobson, M. A., Besch, C. L., Child, C., Hafner, R., Matts, J. P., Muth, K., Wentworth, D. N., Neaton, J. D., Abrams, D., Rimland, D., Perez, G., Grant, I. H., Saravolatz, L. D., Brown, L. S., Deyton, L. and the Terry Beirn Community Programs for Clinical Research on AIDS. 'Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: Results of a randomized trial', Journal of Infectious Diseases, 169, 384-394 (1994).
19. Carlin, B. P., Chaloner, K., Church, T., Louis, T. A. and Matts, J. 'Bayesian approaches for monitoring clinical trials with an application to toxoplasmic encephalitis prophylaxis', The Statistician, 42, 355-367 (1993).
20. Cox, D. R. and Oakes, D. Analysis of Survival Data, Chapman and Hall, London, 1984.
21. Wasserman, L. and Kadane, J. B. 'Computing bounds on expectations', Journal of the American Statistical Association, 87, 516-522 (1992).
22. Gelfand, A. E. and Smith, A. F. M. 'Sampling-based approaches to calculating marginal densities', Journal of the American Statistical Association, 85, 398-409 (1990).